高级检索
当前位置: 首页 > 详情页

Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [2]Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA [3]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, China [4]Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA [5]Global Oncology One, Houston, USA [6]Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China [7]Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine, Baltimore, USA
出处:
ISSN:

关键词: Multiple CT optimization Adaptive planning Head and neck cancer Intensity-modulated proton therapy

摘要:
Purpose: We aimed to determine whether multiple-CT (MCT) optimization of intensity-modulated proton therapy (IMPT) could improve plan robustness to anatomical changes and therefore reduce the additional need for adaptive planning. Methods and materials: Ten patients with head and neck cancer who underwent IMPT were included in this retrospective study. Each patient had primary planning CT (PCT), a first adaptive planning CT (ACT1), and a second adaptive planning CT (ACT2). Selective robust IMPT plans were generated using each CT data set (PCT, ACT1, and ACT2). Moreover, a MCT optimized plan was generated using the PCT and ACT1 data sets together. Dose distributions optimized using each of the four plans (PCT, ACT1, ACT2, and MCT plans) were re-calculated on ACT2 data. The doses to the target and to organs at risk were compared between optimization strategies. Results: MCT plans for all patients met all target dose and organs-at-risk criteria for all three CT data sets. Target dose and organs-at-risk dose for PCT and ACT1 plans re-calculated on ACT2 data set were compromised, indicating the need for adaptive planning on ACT2 if PCT or ACT1 plans were used. The D-98% of CTV1 and CTV3 of MCT plan re-calculated on ACT2 were both above the coverage criteria. The CTV2 coverage of the MCT plan re-calculated on ACT2 was worse than ACT2 plan. The MCT plan re-calculated on ACT2 data set had lower chiasm, esophagus, and larynx doses than did PCT, ACT1, or ACT2 plans recalculated on ACT2 data set. Conclusions: MCT optimization can improve plan robustness toward anatomical change and may reduce the number of plan adaptation for head and neck cancers. (C) 2019 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学 2 区 核医学
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学 2 区 核医学
JCR分区:
出版当年[2020]版:
Q1 ONCOLOGY Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版:
Q1 ONCOLOGY Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [2]Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA
通讯作者:
通讯机构: [2]Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA [7]Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine, Baltimore, USA [*1]Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine, Baltimore, MD 21287, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43381 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号